Answer of the Day for Jun 30, 2022
TheAnswerPage
JUNE 29, 2022
Has CBDV been evaluated as an anti-seizure medication in clinical trials? Yes, GW Pharmaceuticals (the makers of Epidiolex) had trialed CBDV in adult epilepsy, but the study did not meet its primary endpoint of seizure reduction. That trial did not continue.
Let's personalize your content